908 Devices (MASS) Trading Summary
- Last trading session (23 Oct 2026, 04:55 PM CET)
- Share price increased by 2.52 %.
- Current price: USD 11.43.
- Market capitalization: USD 487.7 million.
- Outstanding shares: 41.3 million.
- Volume in the last 24 hours: USD 6.7 million.
- Year‑to‑date performance: +5.55 % since the previous month‑end.
- 200‑day simple moving average: USD 8.14.
- 52‑week high: USD 13.35 (10 Oct 2026).
- 52‑week low: USD 5.02 (1 Feb 2026).
Related Stock Movements (Last 24 Hours)
| Ticker | Change | Current Price | Market Cap (USD m) | P/E Ratio |
|---|---|---|---|---|
| EBF (Ennis) | +1.69 % | 22.61 | 570.7 | 14.73 |
| LMB (Limbach) | –1.63 % | 47.31 | 576.5 | 19.31 |
| EVC (Entravision Communications) | –0.79 % | 6.22 | 582.3 | 289.58 |
| SHEN (Shenandoah Telecommunications) | +5.53 % | 10.19 | 570.3 | – |
| CLMB (Climb Global) | +1.98 % | 32.09 | 584.6 | 28.14 |
Shenandoah Telecommunications (SHEN)
- Declared a cash dividend of $0.12 per share payable on 1 Dec 2026 to shareholders of record as of 2 Nov 2026.
- Dividend is 9 % higher (≈$0.01) than the prior year’s payment.
- No additional guidance was issued.
Climb Global (CLMB)
- Completed acquisition of NeoVAD, a French IT distributor, reported in an SEC 8‑K filing on 21 Oct 2026.
- Purchase included all shares of NeoVAD for a negotiated consideration.
- The deal aims to expand Climb’s European footprint and enhance vendor relationships in cybersecurity, cloud services, and virtualization.
- Management anticipates synergies and an accretive impact on earnings before interest, taxes, depreciation, and amortization.
- The transaction followed standard representations, warranties, covenants, and post‑closing adjustments.
Company Overview – 908 Devices
- Location: Boston, Massachusetts, United States.
- Industry: Medical device manufacturing.
- Products: Analytical devices for chemical and biomolecular analysis, targeting life‑science and field‑forensic markets.
- Website: www.908devices.com .
- Exchange: Nasdaq.
